Steven Hancock, MD

Radiation oncologist

Professor of Radiation Oncology at Stanford University Medical Center

Radiation Oncology

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Cyberknife Stereotactic Radiosurgery Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-725-0084
Learn More About the Clinic Getting Here Make An Appointment

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Skin Cancer Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Urologic Cancer Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Cyberknife Stereotactic Radiosurgery Program at Advanced Medicine Center Building

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-725-0084
Learn More About the Clinic Getting Here Make An Appointment

Cyberknife Stereotactic Radiosurgery Program at Boswell Building

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-0084
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: Stanford University School of Medicine (1981) CA

Residency: Stanford University School of Medicine (1980) CA

Residency: Stanford University School of Medicine (1978) CA

Internship: Stanford University School of Medicine (1977) CA

Board Certification: Therapeutic Radiology, American Board of Radiology (1982)

Board Certification: Internal Medicine, American Board of Internal Medicine (1980)

Medical Education: Stanford University School of Medicine (1976) CA

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Automatic Prostate Tracking and Motion Assessment in Volumetric Modulated Arc Therapy With an Electronic Portal Imaging Device
Diego Azcona, J., Li, R., Mok, E., Hancock, S., & Xing, L. (2013). Automatic Prostate Tracking and Motion Assessment in Volumetric Modulated Arc Therapy With an Electronic Portal Imaging Device. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86(4), 762-768.

Development and clinical evaluation of automatic fiducial detection for tumor tracking in cine megavoltage images during volumetric modulated arc therapy
Azcona, J. D., Li, R., Mok, E., Hancock, S., & Xing, L. (2013). Development and clinical evaluation of automatic fiducial detection for tumor tracking in cine megavoltage images during volumetric modulated arc therapy. MEDICAL PHYSICS, 40(3).

Esophageal tolerance to high-dose stereotactic ablative radiotherapy
Abelson, J. A., Murphy, J. D., Loo, B. W., Chang, D. T., Daly, M. E., & Gibbs, I. C. (2012). Esophageal tolerance to high-dose stereotactic ablative radiotherapy. DISEASES OF THE ESOPHAGUS, 25(7), 623-629.

Testicular Cancer Clinical Practice Guidelines in Oncology
Motzer, R. J., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., & Wilder, R. B. (2012). Testicular Cancer Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(4), 502-535.

Kidney cancer.
Motzer, R. J., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., & Wilder, R. B. (2011). Kidney cancer. Journal of the National Comprehensive Cancer Network , 9(9), 960-977.

Clinical development of a failure detection-based online repositioning strategy for prostate IMRT-Experiments, simulation, and dosimetry study
Liu, W., Qian, J., Hancock, S. L., Xing, L., & Luxton, G. (2010). Clinical development of a failure detection-based online repositioning strategy for prostate IMRT-Experiments, simulation, and dosimetry study. MEDICAL PHYSICS, 37(10), 5287-5297.

NCCN clinical practice guidelines in oncology: testicular cancer.
Motzer, R. J., Agarwal, N., Beard, C., Bolger, G. B., Boston, B., & Wang, J. (2009). NCCN clinical practice guidelines in oncology: testicular cancer. Journal of the National Comprehensive Cancer Network , 7(6), 672-693.

NCCN clinical practice guidelines in oncology: kidney cancer.
Motzer, R. J., Agarwal, N., Beard, C., Bolger, G. B., Boston, B., & Wang, J. (2009). NCCN clinical practice guidelines in oncology: kidney cancer. Journal of the National Comprehensive Cancer Network , 7(6), 618-630.

Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease
Kwong, A., Hancock, S. L., Bloom, J. R., Pal, S., Birdwell, R. L., & Ikeda, D. M. (2008). Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease. BREAST JOURNAL, 14(1), 39-48.

Radiotherapy after prostatectomy: Improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
Spiotto, M. T., Hancock, S. L., & King, C. R. (2007). Radiotherapy after prostatectomy: Improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 69(1), 54-61.

A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking.
Ho, A. K., Fu, D., Cotrutz, C., Hancock, S. L., Chang, S. D., & Adler, J. R. (2007). A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery, 60(2), ONS147-56.

Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease
Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., & Hancock, S. L. (2007). Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(1), 43-49.

Testicular cancer. Clinical practice guidelines in oncology.
Motzer, R. J., Bolger, G. B., Boston, B., Carducci, M. A., Fishman, M., & Sheinfeld, J. (2006). Testicular cancer. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network , 4(10), 1038-1058.

Kidney cancer. Clinical practice guidelines in oncology.
Motzer, R. J., Bolger, G. B., Boston, B., Carducci, M. A., Fishman, M., & Sheinfeld, J. (2006). Kidney cancer. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network , 4(10), 1072-1081.

Breast cancer screening in women surviving Hodgkin disease
Bloom, J. R., Stewart, S. L., & Hancock, S. L. (2006). Breast cancer screening in women surviving Hodgkin disease. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 29(3), 258-266.

Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation
Patel, D. A., Kochanski, J., Suen, A. W., Fajardo, L. F., Hancock, S. L., & Knox, S. J. (2006). Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation. CANCER, 106(3), 718-725.

Diastolic dysfunction after mediastinal irradiation
Heidenreich, P. A., Hancock, S. L., Vagelos, R. H., Lee, B. K., & Schnittger, I. (2005). Diastolic dysfunction after mediastinal irradiation. AMERICAN HEART JOURNAL, 150(5), 977-982.

Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy
Mauch, P., Ng, A., Aleman, B., Carde, P., Constine, L., & Yahalom, J. (2005). Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy. EUROPEAN JOURNAL OF HAEMATOLOGY, 75, 68-76.

Metabolism of the 16-androstene steroids in primary cultured porcine hepatocytes
Sinclair, P. A., Hancock, S., Gilmore, W. J., & Squires, E. J. (2005). Metabolism of the 16-androstene steroids in primary cultured porcine hepatocytes. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 96(1), 79-87.

Testicular cancer. Clinical practice guidelines.
Motzer, R. J., Bahnson, R. R., Boston, B., Carducci, M. A., Fishman, M., & Urban, D. A. (2005). Testicular cancer. Clinical practice guidelines. Journal of the National Comprehensive Cancer Network , 3(1), 52-76.

Kidney cancer. Clinical practice guidelines.
Motzer, R. J., Carducci, M. A., Fishman, M., Hancock, S. L., Hauke, R. J., & Urban, D. A. (2005). Kidney cancer. Clinical practice guidelines. Journal of the National Comprehensive Cancer Network , 3(1), 84-93.

A systolic murmur is a common presentation of aortic regurgitation detected by echocardiography
Heidenreich, P. A., Schnittger, I., Hancock, S. L., & Atwood, J. E. (2004). A systolic murmur is a common presentation of aortic regurgitation detected by echocardiography. CLINICAL CARDIOLOGY, 27(9), 502-506.

Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes?
King, C. R., Presti, J. C., Gill, H., Brooks, J., & Hancock, S. L. (2004). Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 59(2), 341-347.

Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate
Luxton, G., Hancock, S. L., & Boyer, A. L. (2004). Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 59(1), 267-284.

Asymptomatic cardiac disease following mediastinal irradiation
Heidenreich, P. A., Hancock, S. L., Lee, B. K., Mariscal, C. S., & Schnittger, I. (2003). Asymptomatic cardiac disease following mediastinal irradiation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 42(4), 743-749.

Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI
Hsia, A. W., Katz, J. S., Hancock, S. L., & Peterson, K. (2003). Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI. NEUROLOGY, 60(10), 1694-1696.

Role of beam orientation optimization in intensity-modulated radiation therapy
Pugachev, A., Li, J. G., Boyer, A. L., Hancock, S. L., Le, Q. T., & Xing, L. (2001). Role of beam orientation optimization in intensity-modulated radiation therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 50(2), 551-560.

Management of breast cancer after Hodgkin's disease
Wolden, S. L., Hancock, S. L., Carlson, R. W., Goffinet, D. R., Jeffrey, S. S., & Hoppe, R. T. (2000). Management of breast cancer after Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 18(4), 765-772.

Hodgkin's Lymphoma: Choice of Therapy and Late Complications.
Linch, D. C., Gosden, R. G., Tulandi, T., Tan, S. L., & Hancock, S. L. (2000). Hodgkin's Lymphoma: Choice of Therapy and Late Complications. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 205-221.

Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: A preliminary report
Poen, J. C., Golby, A. J., Forster, K. M., Martin, D. P., Chinn, D. M., & Adler, J. R. (1999). Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: A preliminary report. NEUROSURGERY, 45(6), 1299-1305.

The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
Donaldson, S. S., Hancock, S. L., & Hoppe, R. T. (1999). The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. cancer journal from Scientific American, 5(6), 325-333.

Radiation therapy for clinically localized prostate cancer - A multi-institutional pooled analysis
Shipley, W. U., Thames, H. D., Sandler, H. M., Hanks, G. E., Zietman, A. L., & Smith, C. D. (1999). Radiation therapy for clinically localized prostate cancer - A multi-institutional pooled analysis. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 281(17), 1598-1604.

Image-guided robotic radiosurgery
Adler, J. R., Murphy, M. J., Chang, S. D., & Hancock, S. L. (1999). Image-guided robotic radiosurgery. Neurosurgery, 44(6), 1299-306; discussion 1306-7.

Treatment of cavernous sinus tumors with linear accelerator radiosurgery
Chang, S. D., Doty, J. R., Martin, D. P., Hancock, S. L., & Adler, J. R. (1999). Treatment of cavernous sinus tumors with linear accelerator radiosurgery. SKULL BASE SURGERY, 9(3), 195-199.

Clinical experience with image-guided robotic radiosurgery (the Cyberknife) in the treatment of brain and spinal cord tumors
Chang, S. D., Murphy, M., Geis, P., Martin, D. P., Hancock, S. L., & Adler, J. R. (1998). Clinical experience with image-guided robotic radiosurgery (the Cyberknife) in the treatment of brain and spinal cord tumors. NEUROLOGIA MEDICO-CHIRURGICA, 38(11), 780-783.

Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma - Report of two cases
Chang, S. D., Poen, J., Hancock, S. L., Martin, D. P., & Adler, J. R. (1998). Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma - Report of two cases. JOURNAL OF NEUROSURGERY, 89(2), 321-325.

Clinical uses of radiosurgery
Chang, S. D., Adler, J. R., & Hancock, S. L. (1998). Clinical uses of radiosurgery. ONCOLOGY-NEW YORK, 12(8), 1181-?.

Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery
Chang, S. D., Meisel, J. A., Hancock, S. L., Martin, D. P., McManus, M., & Adler, J. R. (1998). Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. NEUROSURGERY, 43(1), 28-34.

Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer
Eulau, S. M., Tate, D. J., Stamey, T. A., Bagshaw, M. A., & Hancock, S. L. (1998). Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 41(4), 735-740.

Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)
Gross, C., Stamey, T., Hancock, S., & Feldman, D. (1998). Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). JOURNAL OF UROLOGY, 159(6), 2035-2039.

Node-positive prostatic cancer: Taps or a call to arms?
Hancock, S. L. (1998). Node-positive prostatic cancer: Taps or a call to arms?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 40(4), 757-759.

Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation
Horning, S. J., Hoppe, R. T., Mason, J., Brown, B. W., Hancock, S. L., & Rosenberg, S. A. (1997). Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. JOURNAL OF CLINICAL ONCOLOGY, 15(5), 1736-1744.

Gastrointestinal cancer after treatment of Hodgkin's disease
Birdwell, S. H., Hancock, S. L., Varghese, A., Cox, R. S., & Hoppe, R. T. (1997). Gastrointestinal cancer after treatment of Hodgkin's disease. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 37(1), 67-73.

The cyberknife: A frameless robotic system for radiosurgery
Adler, J. R., Chang, S. D., MURPHY, M. J., Doty, J., Geis, P., & Hancock, S. L. (1997). The cyberknife: A frameless robotic system for radiosurgery. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 69(1-4), 124-128.

Linear accelerator-based stereotaxic radiosurgery for brain metastases: The influence of number of lesions on survival
Joseph, J., Adler, J. R., Cox, R. S., & Hancock, S. L. (1996). Linear accelerator-based stereotaxic radiosurgery for brain metastases: The influence of number of lesions on survival. JOURNAL OF CLINICAL ONCOLOGY, 14(4), 1085-1092.

Second cancers after Hodgkin's disease in childhood
Donaldson, S. S., & Hancock, S. L. (1996). Second cancers after Hodgkin's disease in childhood. NEW ENGLAND JOURNAL OF MEDICINE, 334(12), 792-794.

Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
Hancock, S. L., & Hoppe, R. T. (1996). Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Seminars in radiation oncology, 6(3), 225-242.

PROSTATE-SPECIFIC ANTIGEN AFTER RADIOTHERAPY FOR PROSTATE-CANCER - A REEVALUATION OF LONG-TERM BIOCHEMICAL CONTROL AND THE KINETICS OF RECURRENCE IN PATIENTS TREATED AT STANFORD-UNIVERSITY
Hancock, S. L., Cox, R. S., & Bagshaw, M. A. (1995). PROSTATE-SPECIFIC ANTIGEN AFTER RADIOTHERAPY FOR PROSTATE-CANCER - A REEVALUATION OF LONG-TERM BIOCHEMICAL CONTROL AND THE KINETICS OF RECURRENCE IN PATIENTS TREATED AT STANFORD-UNIVERSITY. JOURNAL OF UROLOGY, 154(4), 1412-1417.

BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT
Bartlett, N. L., Rosenberg, S. A., Hoppe, R. T., Hancock, S. L., & Horning, S. J. (1995). BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT. JOURNAL OF CLINICAL ONCOLOGY, 13(5), 1080-1088.

STEM-CELL FACTOR ENHANCES THE SURVIVAL OF MURINE INTESTINAL STEM-CELLS AFTER PHOTON IRRADIATION
Leigh, B. R., Khan, W., Hancock, S. L., & Knox, S. J. (1995). STEM-CELL FACTOR ENHANCES THE SURVIVAL OF MURINE INTESTINAL STEM-CELLS AFTER PHOTON IRRADIATION. RADIATION RESEARCH, 142(1), 12-15.

THYROID ABNORMALITIES AFTER THERAPEUTIC EXTERNAL RADIATION
Hancock, S. L., McDougall, I. R., & Constine, L. S. (1995). THYROID ABNORMALITIES AFTER THERAPEUTIC EXTERNAL RADIATION. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 31(5), 1165-1170.

CONTROL OF PROSTATE-CANCER WITH RADIOTHERAPY - LONG-TERM RESULTS
Bagshaw, M. A., Cox, R. S., & Hancock, S. L. (1994). CONTROL OF PROSTATE-CANCER WITH RADIOTHERAPY - LONG-TERM RESULTS. JOURNAL OF UROLOGY, 152(5), 1781-1785.

STEM-CELL FACTOR ENHANCES THE SURVIVAL OF IRRADIATED HUMAN BONE-MARROW MAINTAINED IN SCID MICE
Leigh, B. R., Webb, S., Hancock, S. L., & Knox, S. J. (1994). STEM-CELL FACTOR ENHANCES THE SURVIVAL OF IRRADIATED HUMAN BONE-MARROW MAINTAINED IN SCID MICE. STEM CELLS, 12(4), 430-435.

COMPUTED-TOMOGRAPHY ASSESSMENT OF SPLENIC SIZE AS A PREDICTOR OF SPLENIC WEIGHT AND DISEASE INVOLVEMENT IN LAPAROTOMY STAGED HODGKINS-DISEASE
Hancock, S. L., SCIDMORE, N. S., Hopkins, K. L., Cox, R. S., & Bergin, C. J. (1994). COMPUTED-TOMOGRAPHY ASSESSMENT OF SPLENIC SIZE AS A PREDICTOR OF SPLENIC WEIGHT AND DISEASE INVOLVEMENT IN LAPAROTOMY STAGED HODGKINS-DISEASE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 28(1), 93-99.

FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE
Hancock, S. L., TUCKER, M. A., & Hoppe, R. T. (1993). FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 270(16), 1949-1955.

THE EFFECT OF STEM-CELL FACTOR ON IRRADIATED HUMAN BONE-MARROW
Leigh, B. R., Hancock, S. L., & Knox, S. J. (1993). THE EFFECT OF STEM-CELL FACTOR ON IRRADIATED HUMAN BONE-MARROW. CANCER RESEARCH, 53(17), 3857-3859.

CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS
Hancock, S. L., Donaldson, S. S., & Hoppe, R. T. (1993). CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS. JOURNAL OF CLINICAL ONCOLOGY, 11(7), 1208-1215.

BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE
Hancock, S. L., TUCKER, M. A., & Hoppe, R. T. (1993). BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 85(1), 25-31.

RADIATION OR SURGERY FOR CARCINOMA OF THE ESOPHAGUS - THE ROLE OF ORGAN-CONSERVING THERAPY
Hancock, S. L. (1993). RADIATION OR SURGERY FOR CARCINOMA OF THE ESOPHAGUS - THE ROLE OF ORGAN-CONSERVING THERAPY. ORGAN CONSERVATION IN CURATIVE CANCER TREATMENT, 27, 103-117.

THYROID-DISEASES AFTER TREATMENT OF HODGKINS-DISEASE
Hancock, S. L., Cox, R. S., & McDougall, I. R. (1991). THYROID-DISEASES AFTER TREATMENT OF HODGKINS-DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 325(9), 599-605.

INTERLEUKIN-1-BETA INITIALLY SENSITIZES AND SUBSEQUENTLY PROTECTS MURINE INTESTINAL STEM-CELLS EXPOSED TO PHOTON RADIATION
Hancock, S. L., Chung, R. T., Cox, R. S., & KALLMAN, R. F. (1991). INTERLEUKIN-1-BETA INITIALLY SENSITIZES AND SUBSEQUENTLY PROTECTS MURINE INTESTINAL STEM-CELLS EXPOSED TO PHOTON RADIATION. CANCER RESEARCH, 51(9), 2280-2285.

FINAL REPORT OF THE PHASE-I TRIAL OF THE HYPOXIC CELL RADIOSENSITIZER SR-2508 (ETANIDAZOLE) RADIATION-THERAPY ONCOLOGY GROUP-83-03
Coleman, C. N., Wasserman, T. H., Urtasun, R. C., Halsey, J., Noll, L., & Phillips, T. L. (1990). FINAL REPORT OF THE PHASE-I TRIAL OF THE HYPOXIC CELL RADIOSENSITIZER SR-2508 (ETANIDAZOLE) RADIATION-THERAPY ONCOLOGY GROUP-83-03. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 18(2), 389-393.

Current Stanford clinical trials for Hodgkin's disease.
Hoppe, R. T., Horning, S. J., Hancock, S. L., & Rosenberg, S. A. (1989). Current Stanford clinical trials for Hodgkin's disease. Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, 117, 182-190.

VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE
Horning, S. J., Hoppe, R. T., Hancock, S. L., & Rosenberg, S. A. (1988). VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 6(12), 1822-1831.

INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS
Hancock, S. L., Hoppe, R. T., Horning, S. J., & Rosenberg, S. A. (1988). INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS. ANNALS OF INTERNAL MEDICINE, 109(3), 183-189.